https://www.halaven.com/hcp 2022-09-29 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/baseline-characteristics 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/dose-modifications 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/dosing-admin-menu 2022-11-14 always https://www.halaven.com/hcp/advanced-liposarcoma/dosing-and-administration 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/eap 2025-11-25 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/efficacy 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/efficacy-menu 2022-11-14 always https://www.halaven.com/hcp/advanced-liposarcoma/faqs 2023-12-15 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/important-safety-information 2023-01-16 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/moa 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/patient-characteristics 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/patient-monitoring 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/preparation-and-storage 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/resources-menu 2022-11-14 always https://www.halaven.com/hcp/advanced-liposarcoma/safety-profile 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/site-map 2023-12-15 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/treatment-landscape 2023-12-14 daily 0.5 https://www.halaven.com/hcp/advanced-liposarcoma/trial-design 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/appropriate-patient 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/baseline-patient-characteristics 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/dose-modifications 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/dosing-and-administration 2023-12-15 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/efficacy 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/efficacy-menu 2022-11-14 always https://www.halaven.com/hcp/metastatic-breast-cancer/faqs 2023-12-18 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/important-safety-information 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-allison 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-assistance 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-janet 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-kim 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-monitoring 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-profiler 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/patient-selection-menu 2022-11-14 always https://www.halaven.com/hcp/metastatic-breast-cancer/preparation-and-storage 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/real-world-evidence 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/resources-menu 2023-01-30 always https://www.halaven.com/hcp/metastatic-breast-cancer/safety-and-dosing 2022-09-30 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/safety-dosing-menu 2022-11-14 always https://www.halaven.com/hcp/metastatic-breast-cancer/safety-profile 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/site-map 2023-12-15 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/subgroup-analysis 2023-12-14 daily 0.5 https://www.halaven.com/hcp/metastatic-breast-cancer/trial-design 2023-12-14 daily 0.5